Abbisko Therapeutics

Abbisko Therapeutics

Latest funding
$28,000,000
Venture capital (Series A) - 2017
Lilly Asia Ventures Sinopharm Capital Jianxin Capital +1
Team Size
1–10
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Abbisko Therapeutics makes some noise.